Intuitive Surgical (ISRG) 44th Annual J.P. Morgan Healthcare Conference summary
Event summary combining transcript, slides, and related documents.
44th Annual J.P. Morgan Healthcare Conference summary
16 Jan, 2026Strategic vision and mission
Focus on robotics, AI, advanced imaging, and intelligent technology to improve healthcare outcomes and expand access globally.
Mission and vision have driven talent recruitment and innovation for 30 years, with a durable outlook.
Strategy guided by the Quintuple Aim: improving outcomes, lowering costs, expanding access, and measuring impact.
Vision for a future with less invasive, faster treatments and early disease identification.
Customer-centric approach, with continuous feedback shaping product development and service delivery.
Customer and patient impact
Over 20.4 million patients served globally, with procedures performed in more than 70 countries.
Significant growth in procedures outside the US, rising from 17% in 2005 to 35% in 2025.
Net Promoter Score reached 76 in 2025, classified as world class.
2025 performance highlights
Achieved 20 million cumulative procedures, with 3.2 million performed in 2025.
1,900 systems placed in 2025, growing installed base to over 12,000 globally.
19% year-over-year procedure growth, 13% installed base growth, and 21% revenue growth to $10 billion.
84% of 2025 revenue was recurring.
Latest events from Intuitive Surgical
- Board recommends approval of all annual meeting proposals, including director elections and compensation.ISRG
Proxy Filing13 Mar 2026 - Shareholders to vote on board, pay, auditor, and equity plan amid strong growth and governance.ISRG
Proxy Filing13 Mar 2026 - Board elections, strong financial growth, and all management proposals approved; shareholder proposals rejected.ISRG
AGM 20253 Feb 2026 - Q2 revenue up 14% to $2.01B–$2.2B, driven by strong procedure and system growth.ISRG
Q2 20243 Feb 2026 - Strong 2025 growth and da Vinci 5 adoption drive continued expansion into 2026.ISRG
Q4 202522 Jan 2026 - Da Vinci 5 launch drives strong placements and positive feedback, supporting robust financial outlook.ISRG
2024 Wells Fargo Healthcare Conference22 Jan 2026 - Q3 2024 revenue up 17% to $2.04B, net income up 36% to $565M, with strong system growth.ISRG
Q3 202419 Jan 2026 - Da Vinci 5 launch, innovation, and global growth drive momentum in minimally invasive care.ISRG
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026 - Q4 2024 revenue up 25% with strong da Vinci growth; 2025 outlook cautious on margins.ISRG
Q4 20249 Jan 2026